Talk:Eric Rubin
This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
New Biography for Eric J. Rubin
editEric Joseph Rubin (born 1958) is an American microbiologist and infectious disease specialist1. He is a Professor of Medicine at Harvard Medical School, an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and the Editor-in-Chief of the New England Journal of Medicine2 and NEJM Group.
Personal life Rubin was born and raised in Brockton, Massachusetts. His father, Morris Rubin, was a salesman and his mother, Paula (Schechet) Rubin, was a school librarian. He is married to Akiyo Fujii and has two children, Alexander and Daniel.
Education and career Rubin graduated from Brockton High School, Harvard College (AB, 1980) and Tufts University (MD and PhD, 1990).7 As a graduate student he studied the mechanism of action of botulinum toxins with D. Michael Gill. Rubin trained in Internal Medicine and Infectious Disease at the Massachusetts General Hospital and went on to postdoctoral work in John Mekalanos’ lab at Harvard Medical School.3,4 There he studied Vibrio cholerae, Haemophilus influenzae and Mycobacterium smegmatis. His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis.
Rubin joined the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department. His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study Mycobacterium tuberculosis5 and related organisms. With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development. 6 He is also an infectious disease clinician who sees patients at Brigham and Women’s Hospital, where he is an Associate Physician.
In 2019, Rubin was appointed Editor-in-Chief of the Journal, where he had previously served as an Associate Editor, and NEJM Group, the publishing division of the Massachusetts Medical Society. During the Covid-19 outbreak, the Journal added a weekly podcast9 and rapidly published many studies, including the first description of SARS-CoV-2, the causative virus. During Rubin’s tenure, NEJM Group has also launched two more publications, NEJM Evidence and NEJM AI.
Rubin has worked extensively in international settings and has been involved on advisory boards for several national and global organizations. He is a member of the American Academy of Microbiology, the American Association of Physicians, and the National Academy of Medicine. He also serves on the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).10
References
- "Eric J. Rubin, MD, PhD – Brigham and Women's Hospital". physiciandirectory.brighamandwomens.org. Retrieved 2024-05-31.
- "Eric Rubin named editor-in-chief of New England Journal of Medicine". www.hsph.harvard.edu/news. 2019-06-19. Retrieved 2024-05-31.
- "Eric Rubin". hsph.harvard.edu. Retrieved 2024-05-31.
- "Eric Rubin". catalyst.harvard.edu. Retrieved 2024-05-31.
- "Eric Rubin". Google scholar Retrieved 2024-05-31.
- "Scientist at Work, Scientist at Play". Harvard Public Health Magazine. 2018-12-14. Retrieved 2024-05-31.
- NEJM Evidence - Retrieved 2024-05-31.
- NEJM AI - Retrieved 2024-05-31.
- NEJM Podcasts - Retrieved 2024-05-31.
- VRBPAC- Retrieved 2024-05-31.
Dawn-NEJMGroup (talk) 14:14, 31 May 2024 (UTC)
This edit request by an editor with a conflict of interest has now been answered. |
- Please comply with the relevant policy (WP:COI) by stating your conflict of interest on your user page. Axad12 (talk) 09:56, 16 August 2024 (UTC)
- Not done for now Multiple parts of the draft are currently unsourced. Ideally, especially for biographies of living people, every fact should be sourced somewhere. Also, many of the sources you give are either too vague (e.g. NEJM's podcast feed to source the fact that Rubin was appointed Editor-in-Chief(?) and that the podcast was launched during the Covid-19 outbreak) or too directly connected to the subject (Rubin's profile in multiple websites). A Google search is also not an acceptable source by itself. Chaotic Enby (talk · contribs) 09:55, 13 September 2024 (UTC)
- Eric Joseph Rubin (born 1958) is an American microbiologist and infectious disease specialist.1 He is a Professor of Medicine at Harvard Medical School, an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health2 and the Editor-in-Chief of the New England Journal of Medicine and NEJM Group. 3
- Personal life
- Rubin was born and raised in Brockton, Massachusetts. His father, Morris Rubin, was a salesman and his mother, Paula (Schechet) Rubin, was a school librarian. He is married to Akiyo Fujii and has two children, Alexander and Daniel.
- Education and career
- Rubin graduated from Brockton High School, Harvard College (AB, 1980) and Tufts University (MD and PhD, 1990).4 As a graduate student he studied the mechanism of action of botulinum toxins with D. Michael Gill. 5 Rubin trained in Internal Medicine and Infectious Disease at the Massachusetts General Hospital6 and went on to postdoctoral work in John Mekalanos’ lab at Harvard Medical School.7 There he studied Vibrio cholerae, Haemophilus influenzae and Mycobacterium smegmatis.8 His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis. 9
- Rubin joined the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department. 10 His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study Mycobacterium tuberculosis and related organisms. 11 With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development.12 He is also an infectious disease clinician who sees patients at Brigham and Women’s Hospital, where he is an Associate Physician. 13
- In 2019, Rubin was appointed Editor-in-Chief of the Journal, where he had previously served as an Associate Editor, and NEJM Group, the publishing division of the Massachusetts Medical Society. 14 During the Covid-19 outbreak, the Journal recorded several podcast episodes15 and rapidly published many studies, including the first description of SARS-CoV-2, the causative virus. 16 During Rubin’s tenure, NEJM Group has also launched two more publications, NEJM Evidence17 and NEJM AI.18
- Rubin has worked extensively in international settings and has been involved on advisory boards for several national and global organizations. He is a member of the American Academy of Microbiology, the American Association of Physicians, and the National Academy of Medicine.19 He also serves on the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).20
- References
- 1. https://physiciandirectory.brighamandwomens.org/details/1279/eric-rubin-infectious_disease-boston
- 2. https://www.hsph.harvard.edu/profile/eric-rubin/
- 3. https://www.prnewswire.com/news-releases/eric-j-rubin-md-phd-named-editor-in-chief-of-the-new-england-journal-of-medicine--and-nejm-group-300871474.html
- 4. https://www.enterprisenews.com/story/news/local/2019/06/23/brockton-native-named-editor-in/4847232007/
- 5. https://www.fda.gov/media/155882/download
- 6. https://doctors.massgeneralbrigham.org/provider/eric-j-rubin/254559
- 7. https://mekalanoslab.med.harvard.edu/alumni/
- 8. https://www.fda.gov/media/155882/download
- 9. https://patents.justia.com/patent/6368830
- 10. https://www.hsph.harvard.edu/magazine/magazine_article/scientist-at-work-scientist-at-play/
- 11. https://www.hsph.harvard.edu/rubin-lab/research/
- 12. https://www.hsph.harvard.edu/rubin-lab/research/
- 13. https://physiciandirectory.brighamandwomens.org/details/1279/eric-rubin-infectious_disease-boston
- 14. https://www.prnewswire.com/news-releases/eric-j-rubin-md-phd-named-editor-in-chief-of-the-new-england-journal-of-medicine--and-nejm-group-300871474.html
- 15. https://www.nejm.org/do/10.1056/NEJMdo200326/full/
- 16. https://www.nejm.org/doi/full/10.1056/NEJMc2004794
- 17. https://www.nejm.org/doi/full/10.1056/NEJMe2118588
- 18. https://www.statnews.com/2023/12/11/nejm-ai-new-journal-artificial-intelligence-medicine/
- 19. https://www.fda.gov/media/155882/download
- 20. https://www.fda.gov/advisory-committees/vaccines-and-related-biological-products-advisory-committee/roster-vaccines-and-related-biological-products-advisory-committee Dawn-NEJMGroup (talk) 18:55, 26 September 2024 (UTC)